ГОСТ РИСО 20776-1— 2010
Библиография
[1] Comit6 de I’Antibiogramme de la Soctete Frangaise de Microbiotogie. (1966). Technical recommendations
for in vitro susceptibility testing, Clin Microbiol Infect. 2 (suppl 1): S 11— 25
[2]Deutsches Institut fur Normung (1999). Medical microbiology — Susceptibility testing of pathogens to antimicrobial
agents — Part 4: Evaluation classes of the minimum inhibitory concentration. DIN. Berlin, pp. 58940-4
[3]OLSSON-LILJEQUIST. B.. LARSSON. P.. WALDER. M. and MIORNER. H. (1997). Antimicrobial susceptibility testing
in Sweden III. Methodology for susceptibility testing. Scand J Infect Dis. 105 (suppl): 13— 23
[4]ANDREWS. J.M. (2001). Determination of minimum inhibitory concentrations. J Antimicrob Chemother.48 Suppl.
S1: 5-16 (for latest version, see http:/Avww.bsac.org.uk/_db/_documentS’Chapter_two.pdf)
[5]Clinical and Laboratory Standards Institute (2006). Methods for Dilution Antimicrobial SusceptibilityTestsfor Bacteria
That Grow Aerobically. 7th edn. Approved Standard M7— A7. Wayne. PA
[6]European Committee on Antimicrobial Susceptibility Testing.(2003). Determination of minimuminhibitory
concentrations (MICs) of antibacterial agents by broth microdilution. EUCAST DiscussionDocument E.Def 5.1.
Clinl Microbiol Infect: 9 (issue 7 insert): 1— 10 (see
http://www.escmid.orgi‘Seviware/Script/SvFiles.asp?Ref=359
)
[7]Clinical and Laboratory Standards Institute (2006). Performance Standards for Antimicrobial Susceptibility Testing.
16th edn. Informational Supplement M100-S16, Wayne. PA
[8] ERICSSON. H.M.. SHERRIS. J.C. (1971). Antibiotic sensitivity testing. Report of an internationalcollaborative study.
Acta Pathol Microbiol Scand. Sect В 217 (suppl): 1— 90
[9]European Committee on Antimicrobial Susceptibility Testing (2000),Determination of minimum nhibitory
concentrations (MICs) of antibacterial agents by agar dilution. EUCAST Definitive DocumentE.Def 3.1 (for latest
version, see http:/Avww.escmid.org/sites/science/eucastfpages.asp?m=Programmes)
[10] MUELLER. J.H. and HINTON. J. (1941), A protein-free medium for primary isolation of the gonococcus and
meningococcus. Proc Soc ExperBiol Med. 48: 330
[11] MORRISON, G.H. (1969). Critical Reviews in Analytical Chemistry. (14) 28A. CRC Press. Boca Raton. Florida
[12] BARRY. A.L.. MILLER. G.H.. THORNSBERRY. C. etal. (1987). Influenceofcation supplements on activity ofnetilmicin
against
Pse
u
do
m
o
n
a
s
a
e
nx
ji
n
o
s
a
in vitro and in vivo. Antimicrob Agents Chemother. 31:1514— 1518
[13] BARRY. A.L., RELLER. L.B.. MILLER. G.H. et al. (1992), Revision of standards for adjusting the cation content of
Mueller-Hinton broth for testing susceptibility of
Pse
u
do
m
o
n
a
s
a
e
m
gi
n
o
s
a
to aminoglycosides. J. Clin Microbiol.
30: 585-589
[14] FUCHS. P.C.. BARRY. A.L. and BROWN. S.D. (2000), Daptomydn susceptibility tests: interpretive criteria, quality
control and effect of calcium on in vitro tests, Diag Microbiol Infect Dis. 38: 51— 58
[15] DALY. J.S.. DODGE. R.A.. GLEW, R.H.. SQJA. D.T.. DELUCA. B.A. and HEBERT. S. (1997). Effect ofzincconcentration
in Mueller— Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem. J. Clin Microbiol.
35:1027— 1029
[16] European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints and epidemiological cut-off
values (for latest version, see http:/Avww.escmid-ora/sites/science/eucast/paqes.asp?m=Proarammes)
17